Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ) closed at $3.99 on October 26, 2026, down 1.48% on the day. The stock trades 78.0% below its 52-week high of $18.11 and 3.1% above its 52-week low of $3.87. Over the past year, it lost 76.0%. Corbus Pharmaceuticals Holdings, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 23, 2025, CRBP closed higher on 111 days (44%). Its best day was March 9, 2026 (+19.23%) and its worst was May 26, 2026 (-30.31%). The stock moved 10% or more in a single session 7 times.
Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. Its lead product candidate includes JBT-101, a novel oral endocannabinoid-mimetic drug, which is in Phase 2 clinical trials for the treatment of systemic sclerosis, cystic fibrosis, diffuse cutaneous, skin-predominant dermatomyositis, and systemic lupus erythematosus diseases. The company is based in Norwood, Massachusetts.
Find more stocks like CRBP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.